The complaint follows a ProPublica investigation that found Alicia Jackson, a high-ranking federal health official, publicly endorsed a change in hormone therapy policy while owning stock in a company that provides access to menopause treatments.
Nonprofit, investigative journalism on a mission to hold the powerful
to account.
The complaint follows a ProPublica investigation that found Alicia Jackson, a high-ranking federal health official, publicly endorsed a change in hormone therapy policy while owning stock in a company that provides access to menopause treatments.
